SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-18-009290
Filing Date
2018-11-13
Accepted
2018-11-13 17:14:23
Documents
68
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q mrsn-20180930x10q.htm 10-Q 1421621
2 EX-31.1 mrsn-20180930ex311d9cf54.htm EX-31.1 11342
3 EX-31.2 mrsn-20180930ex312ffe10c.htm EX-31.2 13056
4 EX-32.1 mrsn-20180930ex3214238b5.htm EX-32.1 16011
  Complete submission text file 0001558370-18-009290.txt   6984878

Data Files

Seq Description Document Type Size
5 EX-101.INS mrsn-20180930.xml EX-101.INS 1624461
6 EX-101.SCH mrsn-20180930.xsd EX-101.SCH 65079
7 EX-101.CAL mrsn-20180930_cal.xml EX-101.CAL 42333
8 EX-101.DEF mrsn-20180930_def.xml EX-101.DEF 242321
9 EX-101.LAB mrsn-20180930_lab.xml EX-101.LAB 476596
10 EX-101.PRE mrsn-20180930_pre.xml EX-101.PRE 366231
Mailing Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139 617-498-0020
Mersana Therapeutics, Inc. (Filer) CIK: 0001442836 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38129 | Film No.: 181179067
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1